All Type of News
Whan In Pharm signs exclusive agreement of introducing the epilepsy treatment ‘Zebinix’
Whan In Pharm(CEO Won-Bum Lee) signed an exclusive license agreement of ‘Zebinix,’ an epilepsy treatment developed by Portuguese Bial(CEO António Portela), in Korea at the headquarters on the 26th.
‘Zebinix,’ a once-...
Sam Chun Dang Pharm to sign eye drop export agreements of more than KRW 1 trillion in U.S. and Europe
Sam Chun Dang Pharm has drawn attention of the industry as signing export agreements of its eye drops to advanced markets, like the U.S. and Europe. There are three reasons why this is.
According to Sam Chun Dang Pha...
Government to strengthen monitoring system on top sale biologics
In order to create a base to safely use biologics, collection and inspection of products in market will get stricter.
The Ministry of Food and Drug Safety said they would focus on securing the national relief over bi...
Who will lead KPBMA’s ethical management to eradicate illegal rebates?
The ‘National Industry Power Strengthening’ process that the former Chair Heng-Myung Lee and Chairman Hee-Mok Won have carried out will continue while Jung-Hee Lee, Chair of the Korea Pharmaceutical and Bio-Pharma Ass...
1 of 3 medicines approved as incrementally modified drug were ‘antihypertensive’
It was analyzed total 93 products have been approved as incrementally modified drug since the adoption of the incrementally modified drug system in 2009, and 1 of the 3 incrementally modified drugs were antihypertensi...
Hanmi Pharm awarded ‘BPW Gold Award’ for first time as pharma
Hanmi Pharm(CEO Jong-Su Woo, Sae-Chang Kwon) has been awarded the 24th ‘BPW Gold Award’ by the Business & Professional Women Korea(BPW Korea) for the first time as a Korean pharmaceutical company.
The award establish...
Products like ‘Repatha Inj’ & ‘Soolantra Cream 1%’ enter Asan Medical Center
Amgen’s ‘Repatha Inj’ and Galderma’s ‘Soolantra Cream 1%’ entered Asan Medical Center.
At the 142nd Drug Committee, Asan Medical Center approved introduction of ‘Repatha Inj,’ the Amgen Korea’s PCSK9-inhibiting chole...
Dong Wha Pharm’s ‘Zabolante’ and Ildong’s ‘Besivo’ selected New Drug Development Awards
The Korea Drug Research Association(Chairman Dong-Yeon Kim, KDRA) will hold the ‘19th Korea New Drug Development Awards’ at the Geranium Hall of Hotel Samjung on 27 February, 3pm.
The companies which will receive the...
Pharmaceutical inspection on GMP facilities to change to inspection focusing on risk
The pharmaceutical inspection which has been conducted on pharmaceutical companies’ GMP facilities will now focus on the level of risk.
The Ministry of Food and Drug Safety(MFDS) announced to change the pharmaceutica...
161 products including ‘Arnuity’ & ‘Abcertin’ newly registered for NHIS
161 products including ‘Arnuity,’ an asthma therapy, and ‘Abcertin,’ a Gaucher disease treatment, were newly registered in the National Health Insurance Service(NHIS).
The Ministry of Health and Welfare(MOHW) revised...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
